H1N1 influenza virus dose dependent induction of dysregulated innate immune responses and STAT1/3 activation are associated with pulmonary immunopathological damage

References

• Taubenberger JK, Morens DM. Influenza: the once and future pandemic. Public Health Rep. 2010;125(3):16–26.
   PubMedGoogle Scholar
• Taubenberger JK, Kash JC. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe. 2010;7(6):440–451. DOI:10.1016/j.chom.2010.05.009
   PubMed Web of Science ®Google Scholar
• Wu X, Bao L, Hu Z, et al. Ficolin A exacerbates severe H1N1 influenza virus infection- induced acute lung immunopathological injury via excessive complement activation. Cell Mol Immunol. 2021;18(9):2278–2280. DOI:10.1038/s41423-021-00737-1
   PubMed Web of Science ®Google Scholar
• Jia X, Liu B, Bao L, et al. Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration. PLoS Pathog. 2018;14(11):e1007428. DOI:10.1371/journal.ppat.1007428
   PubMed Web of Science ®Google Scholar
• de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza a (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006;12(10):1203–1207. DOI:10.1038/nm1477
   PubMed Web of Science ®Google Scholar
• Xue C, Wen M, Bao L, et al. Vgamma4(+)gammAdeltat cells aggravate severe h1n1 influenza virus infection-induced acute pulmonary immunopathological injury via secreting interleukin-17A. Front Immunol. 2017;8:1054. DOI:10.3389/fimmu.2017.01054
   PubMed Web of Science ®Google Scholar
• Koutsakos M, Kedzierska K, Subbarao K. Immune responses to avian influenza viruses. J Immunol. 2019;202(2):382–391. DOI:10.4049/jimmunol.1801070
   PubMed Web of Science ®Google Scholar
• Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383(23):2255–2273. DOI:10.1056/NEJMra2026131
   PubMed Web of Science ®Google Scholar
• Ichiyama T, Isumi H, Ozawa H, et al. Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy. Scand J Infect Dis. 2003;35(1):59–61. DOI:10.1080/0036554021000026986
   PubMed Web of Science ®Google Scholar
• Channappanavar R, Fehr AR, Zheng J, et al. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest. 2019;129(9):3625–3639. DOI:10.1172/JCI126363
   PubMed Web of Science ®Google Scholar
• Cilloniz C, Pantin-Jackwood MJ, Ni C, et al. Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection. J Virol. 2010;84(15):7613–7624. DOI:10.1128/JVI.00553-10
   PubMed Web of Science ®Google Scholar
• Karki R, Sharma BR, Tuladhar S, et al. Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184(1):149–168. DOI:10.1016/j.cell.2020.11.025
   PubMed Web of Science ®Google Scholar
• La Gruta NL, Kedzierska K, Stambas J, et al. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol. 2007;85(2):85–92. DOI:10.1038/sj.icb.7100026
   PubMed Web of Science ®Google Scholar
• Zhang N, Bao YJ, Tong AH, et al. Whole transcriptome analysis reveals differential gene expression profile reflecting macrophage polarization in response to influenza a H5N1 virus infection. BMC Med Genomics. 2018;11(1):20. DOI:10.1186/s12920-018-0335-0
   PubMedGoogle Scholar
• Geng P, Zhu H, Zhou W, et al. Baicalin inhibits influenza a virus infection via promotion of m1 macrophage polarization. Front Pharmacol. 2020;11:1298. DOI:10.3389/fphar.2020.01298
   PubMed Web of Science ®Google Scholar
• Davis MJ, Tsang TM, Qiu Y, et al. Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection. Mbio. 2013;4(3):e213–64. DOI:10.1128/mBio.00264-13
   Web of Science ®Google Scholar
• Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011;11(11):750–761. DOI:10.1038/nri3088
   PubMed Web of Science ®Google Scholar
• Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958–969. DOI:10.1038/nri2448
   PubMed Web of Science ®Google Scholar
• Ren Y, Khan FA, Pandupuspitasari NS, et al. Immune evasion strategies of pathogens in macrophages: the potential for limiting pathogen transmission. Curr Issues Mol Biol. 2017;21:21–40.
   PubMed Web of Science ®Google Scholar
• Schneider WM, Chevillotte MD, Rice CM. Interferon-Stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32(1):513–545. DOI:10.1146/annurev-immunol-032713-120231
   PubMed Web of Science ®Google Scholar
• Yan Z, Gibson SA, Buckley JA, et al. Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases. Clin Immunol. 2018;189:4–13. DOI:10.1016/j.clim.2016.09.014
   PubMed Web of Science ®Google Scholar
• Ivashkiv LB, Hu X. Signaling by STATs. Arthritis Res Ther. 2004;6(4):159–168. DOI:10.1186/ar1197
   PubMed Web of Science ®Google Scholar
• Ji L, Zhao X, Zhang B, et al. Slc6a8-Mediated creatine uptake and accumulation reprogram macrophage polarization via regulating cytokine responses. Immunity. 2019;51(2):272–284. DOI:10.1016/j.immuni.2019.06.007
   PubMed Web of Science ®Google Scholar
• Huangfu N, Zheng W, Xu Z, et al. RBM4 regulates M1 macrophages polarization through targeting STAT1-mediated glycolysis. Int Immunopharmacol. 2020;83:106432. DOI:10.1016/j.intimp.2020.106432
   PubMed Web of Science ®Google Scholar
• Yin Z, Ma T, Lin Y, et al. IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma. J Cell Biochem. 2018;119(11):9419–9432. DOI:10.1002/jcb.27259
   PubMed Web of Science ®Google Scholar
• Lee B, Gopal R, Manni ML, et al. STAT1 is required for suppression of type 17 immunity during influenza and bacterial superinfection. Immunohorizons. 2017;1(6):81–91. DOI:10.4049/immunohorizons.1700030
   PubMedGoogle Scholar
• Liu B, Bao L, Wang L, et al. Anti-IFN-Gamma therapy alleviates acute lung injury induced by severe influenza a (H1N1) pdm09 infection in mice. J Microbiol Immunol Infect. 2021;54(3):396–403. DOI:10.1016/j.jmii.2019.07.009
   PubMedGoogle Scholar
• Liu B, Zhang X, Deng W, et al. Severe influenza A(H1N1)pdm09 infection induces thymic atrophy through activating innate CD8(+)CD44(hi) T cells by upregulating IFN-γ. Cell Death Dis. 2014;5(10):e1440. DOI:10.1038/cddis.2014.323
   PubMed Web of Science ®Google Scholar
• Smith KM, Mrozek JD, Simonton SC, et al. Prolonged partial liquid ventilation using conventional and high-frequency ventilatory techniques: gas exchange and lung pathology in an animal model of respiratory distress syndrome. Crit Care Med. 1997;25(11):1888–1897. DOI:10.1097/00003246-199711000-00030
   PubMed Web of Science ®Google Scholar
• Zhang J, Ma M, Qin D, et al. Lung morphometry changes in prevention of airway remodeling by protocatechuic aldehyde in asthmatic mice. Int J Clin Exp Med. 2015;8(5):6890–6901.
   PubMed Web of Science ®Google Scholar
• Wei F, Gao C, Wang Y. The role of influenza a virus-induced hypercytokinemia. Crit Rev Microbiol. 2022;48(2):240–256. DOI:10.1080/1040841X.2021.1960482
   PubMed Web of Science ®Google Scholar
• Nemeth T, Sperandio M, Mocsai A. Neutrophils as emerging therapeutic targets. Nat Rev Drug Discov. 2020;19(4):253–275. DOI:10.1038/s41573-019-0054-z
   PubMed Web of Science ®Google Scholar
• Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355–362. DOI:10.1038/s41577-020-0331-4
   PubMed Web of Science ®Google Scholar
• von Ehr a, Attaai A, Neidert N, et al. Inhibition of microglial TGFβ sIgnaling increases expression of Mrc1. Front Cell Neurosci. 2020;14:66. DOI:10.3389/fncel.2020.00066
   PubMed Web of Science ®Google Scholar
• Tarique AA, Logan J, Thomas E, et al. Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. Am J Respir Cell Mol Biol. 2015;53(5):676–688. DOI:10.1165/rcmb.2015-0012OC
   PubMed Web of Science ®Google Scholar
• Kim KS, Jung H, Shin IK, et al. Induction of interleukin-1 beta (IL-1beta) is a critical component of lung inflammation during influenza a (H1N1) virus infection. J Med Virol. 2015;87(7):1104–1112. DOI:10.1002/jmv.24138
   PubMed Web of Science ®Google Scholar
• Volz E, Hill V, Mccrone JT, et al. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell. 2021;184(1):64–75. DOI:10.1016/j.cell.2020.11.020
   PubMed Web of Science ®Google Scholar
• Johansson C, Kirsebom F. Neutrophils in respiratory viral infections. Mucosal Immunol. 2021;14(4):815–827. DOI:10.1038/s41385-021-00397-4
   PubMed Web of Science ®Google Scholar
• Tate MD, Deng YM, Jones JE, et al. Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J Immunol. 2009;183(11):7441–7450. DOI:10.4049/jimmunol.0902497
   PubMed Web of Science ®Google Scholar
• Zhou Z, Ren L, Zhang L, et al. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe. 2020;27(6):883–890. DOI:10.1016/j.chom.2020.04.017
   PubMed Web of Science ®Google Scholar
• Perrone LA, Plowden JK, Garcia-Sastre A, et al. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 2008;4(8):e1000115. DOI:10.1371/journal.ppat.1000115
   PubMed Web of Science ®Google Scholar
• Kulkarni U, Zemans RL, Smith CA, et al. Excessive neutrophil levels in the lung underlie the age-associated increase in influenza mortality. Mucosal Immunol. 2019;12(2):545–554. DOI:10.1038/s41385-018-0115-3
   PubMed Web of Science ®Google Scholar
• Tang BM, Shojaei M, Teoh S, et al. Neutrophils-Related host factors associated with severe disease and fatality in patients with influenza infection. Nat Commun. 2019;10(1):3422. DOI:10.1038/s41467-019-11249-y
   PubMedGoogle Scholar
• Byrne AJ, Mathie SA, Gregory LG, et al. Pulmonary macrophages: key players in the innate defence of the airways. Thorax. 2015;70(12):1189–1196. DOI:10.1136/thoraxjnl-2015-207020
   PubMed Web of Science ®Google Scholar
• Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–6440. DOI:10.1002/jcp.26429
   PubMed Web of Science ®Google Scholar
• Schoggins JW, Rice CM. Interferon-Stimulated genes and their antiviral effector functions. Curr Opin Virol. 2011;1(6):519–525. DOI:10.1016/j.coviro.2011.10.008
   PubMed Web of Science ®Google Scholar
• Lee B, Gopal R, et al. STAT1 is required for suppression of type 17 immunity during influenza and bacterial superinfection. Immunohorizons. 2017;1(6):81–91. DOI:10.4049/immunohorizons.1700030
   PubMedGoogle Scholar
• Liu S, Liao Y, Chen B, et al. Critical role of Syk-dependent STAT1 activation in innate antiviral immunity. Cell Rep. 2021;34(3):108627. DOI:10.1016/j.celrep.2020.108627
   PubMed Web of Science ®Google Scholar
• Vairo D, Tassone L, Tabellini G, et al. Severe impairment of IFN-gamma and IFN-alpha responses in cells of a patient with a novel STAT1 splicing mutation. Blood. 2011;118(7):1806–1817. DOI:10.1182/blood-2011-01-330571
   PubMed Web of Science ®Google Scholar
• Herishanu Y, Tadmor T, Braester A, et al. Low-Dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: the Israeli CLL study group experience. Hematol Oncol. 2019;37(2):185–192. DOI:10.1002/hon.2580
   PubMed Web of Science ®Google Scholar
• Chaudhuri A, Yang B, Gendelman HE, et al. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood. 2008;111(4):2062–2072. DOI:10.1182/blood-2007-05-091207
   PubMed Web of Science ®Google Scholar
• Zhang S, Huo C, Xiao J, et al. P-STAT1 regulates the influenza a virus replication and inflammatory response in vitro and vivo. Virology. 2019;537:110–120. DOI:10.1016/j.virol.2019.08.023
   PubMed Web of Science ®Google Scholar
• Zhu L, Yang P, Zhao Y, et al. Single-Cell sequencing of peripheral mononuclear cells reveals distinct immune response landscapes of COVID-19 and influenza patients. Immunity. 2020;53(3):685–696. DOI:10.1016/j.immuni.2020.07.009
   PubMed Web of Science ®Google Scholar
• Kwok HH, Poon PY, Fok SP, et al. Anti-Inflammatory effects of indirubin derivatives on influenza a virus-infected human pulmonary microvascular endothelial cells. Sci Rep. 2016;6(1):18941. DOI:10.1038/srep18941
   PubMedGoogle Scholar
• Ampomah PB, Moraes LA, Lukman HM, et al. Formyl peptide receptor 2 is regulated by RNA mimics and viruses through an IFN-beta-STAT3-dependent pathway. FASEB J. 2018;32(3):1468–1478. DOI:10.1096/fj.201700584RR
   PubMed Web of Science ®Google Scholar
• Pleschka S, Wolff T, Ehrhardt C, et al. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat Cell Biol. 2001;3(3):301–305. DOI:10.1038/35060098
   PubMed Web of Science ®Google Scholar